Form 4 for TCRX TScan Therapeutics, Inc.
Accepted 2023-12-18 00:00:00 ET · period of report 2023-12-14 · accession 0000950170-23-071208 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2023-12-18 | 2023-12-14 | TCRX | Klencke Barbara | Dir | P - Purchase | $5.08 | +5,000 | 30.0K | +20% | +$25.4K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Voting Common Stock | 2023-12-14 | P | A | 5,000 | $5.08 | 30,000 | D | — | — |